<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>Epstein-Barr-virus (EBV)-positive Burkitt's-<z:hpo ids='HP_0002665'>lymphoma</z:hpo> (<z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e>) cell lines are not recognized by EBV-specific T cells, due to their non-immunogenic phenotype and restricted expression of latent EBV genes </plain></SENT>
<SENT sid="1" pm="."><plain>We tested whether triggering of CD40 can alter the phenotype of the <z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> cells with regard to: (i) expression of surface markers, (ii) expression of <z:mp ids='MP_0001799'>viral</z:mp> antigens, (iii) presentation of endogenous antigens to MHC-class-1 restricted cytotoxic T lymphocytes (CTLs), (iv) stimulatory capacity in allogeneic mixed-lymphocyte cultures (MLCs), (v) sensitivity to natural-killer (NK)-cell-mediated lysis </plain></SENT>
<SENT sid="2" pm="."><plain>Co-culture of EBV-positive <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells with CD40-ligand-transfected L cells induced up-regulation of CD54 and CD80 but did not affect the expression of <z:mp ids='MP_0001799'>viral</z:mp> genes </plain></SENT>
<SENT sid="3" pm="."><plain>In spite of significant up-regulation of TAP1 and TAP2, and increased expression of MHC class 1, the <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells remained unable to present endogenously expressed <z:mp ids='MP_0001799'>viral</z:mp> antigens to EBV-specific CTL </plain></SENT>
<SENT sid="4" pm="."><plain>However, the up-regulation of <z:e sem="disease" ids="C0001511" disease_type="Disease or Syndrome;Acquired Abnormality" abbrv="">adhesion</z:e> and co-stimulatory molecules was associated with increased stimulatory capacity in MLC and enhanced sensitivity to NK cells </plain></SENT>
<SENT sid="5" pm="."><plain>These findings indicate that, while inducing only a modest phenotype shift, cross-linking of CD40 under physiologic conditions may selectively enhance the sensitivity of <z:e sem="disease" ids="AmbiguousAbbrv" disease_type="AmbiguousAbbrv" abbrv="ambiguous">BL</z:e> cells to anti-<z:e sem="disease" ids="C0027651" disease_type="Neoplastic Process" abbrv="">tumor</z:e> immune responses </plain></SENT>
</text></document>